Home | Research Management Partners

clinical research molecular or atomic blue structure.jpg

RMP integrates directly within active medical practices to standardize study execution, reduce variability, and deliver consistent performance across sites.
Research Management Partners | Powered by Physician Management Partners
SMO-MSO

“A Fully Integrated SMO-MSO Network Delivering Predictable Start-Up, Reliable Enrollment, and Centralized Quality Across All Sites.”

KEY DIFFERENTIATORS
“We offer the structure of a large network with the flexibility and patient access of independent practices.”
RMP is designed to operate under real-world study pressure — including delayed enrollment, protocol complexity, and multi-site variability.

INTEGRATION

Fully affiliated research sites under a single SMO governance model.

OVERSIGHT

PREDICTABILITY

INTEGRITY

ACCOUNTABILITY

Real-time, on-site Quality Control with immediate CAPA execution

Predictable IRB and site activation timelines

Clean, audit-ready data across
Phase I-IV trials

Single point of accountability for multi-site programs

ABOUT US

Research Management Partners (RMP) is a U.S.-based Site Management Organization operating a fully integrated and centrally governed clinical research network.

We enable Sponsors and CROs to reduce execution risk and operational variability by delivering standardized processes, real-time quality oversight, and consistent site performance across all locations.

Our model ensures reliable start-up timelines, strong enrollment execution, and audit-ready data—making RMP a strategic partner for scalable, multi-site clinical trials.

We provide direct access to high-performing research sites and experienced investigators across multiple therapeutic areas, supported by an integrated infrastructure designed to ensure quality, compliance, and consistent delivery at every stage of the study lifecycle.

Request Capabilities Deck

“…including Internal Medicine, Gastroenterology, and specialty investigators, enhancing both patient access and therapeutic coverage.”

If your study is delayed, under-enrolling, or operationally inconsistent — we should talk.

“Our teams have operated directly within platforms such as Medidata Solutions, Veeva Systems, and Oracle Health Sciences at the site level—where data quality is truly determined. Technology alone does not guarantee clean data; execution at the point of care does. RMP’s embedded model enforces standardized SOPs, real-time quality control, and full operational alignment from study start.”

Network Metrics & Operational Performance

Research Management Partners (RMP) operates a growing clinical research network supported by Physician Management Partners, providing access to diverse patient populations and experienced investigators across multiple therapeutic areas.

Our operational model focuses on predictable timelines, centralized oversight, and consistent quality standards across all affiliated sites.

Network Overview

• 30+ affiliated clinical research sites across Florida and Puerto Rico,

As our network expands across the United States, RMP maintains a continuous “boots-on-the-ground” presence within affiliated sites, actively supervising study conduct, enforcing standardized SOPs, and operating an internal quality control network to ensure regulatory compliance and data integrity.
• 70+ physicians and sub-investigators within the network
• Access to a large and diverse patient population through affiliated medical practices
• Experience supporting Phase I–IV clinical trials
• Multispecialty investigator network covering major therapeutic areas

Operational Capabilities

• Centralized regulatory and quality oversight
• Standardized SOP framework across sites
• Rapid feasibility response and site activation readiness
• Structured patient recruitment through clinic networks
• Continuous monitoring of quality and protocol adherence

This integrated model enables RMP to deliver predictable timelines, consistent quality oversight, and reliable enrollment performance for sponsors and CRO partners.

Therapeutic Areas & Investigator Expertise

Research Management Partners (RMP) operates a multispecialty investigator network with experience supporting Phase I–IV clinical trials across a wide range of therapeutic areas.

Through our affiliated physicians, specialty clinics, and embedded SMO oversight model, our network can support interventional, observational, and biospecimen collection studies across diverse patient populations.

Core Therapeutic Areas

• Psychiatry
• Neurology
• Gastroenterology
• Pulmonology / Respiratory Diseases
• Rheumatology
• Dermatology
• Endocrinology / Metabolic Disorders
• Cardiovascular Diseases
• Nephrology
• Internal Medicine
• Infectious Diseases
• Immunology

Additional Clinical Research Areas

• Oncology / Hematology
• Pain Management
• Sleep Disorders
• Allergy and Immunologic Disorders
• Women’s Health / Gynecology
• Men’s Health
• Urology
• Pediatrics
• Geriatric Medicine
• Rare Diseases
• Autoimmune Diseases
• Metabolic and Obesity Disorders

Types of Studies Supported

• Phase I Clinical Trials
• Phase II Clinical Trials
• Phase III Clinical Trials
• Phase IV Post-Marketing Studies
• Device Trials
• Observational Studies
• Real-World Evidence Studies
• Epidemiological Studies
• Biospecimen and Sample Collection Studies
• Registry Studies

Our integrated research infrastructure and continuous site oversight allow us to maintain consistent quality standards while supporting sponsors and CROs across a broad spectrum of clinical development programs.

MEASURABLE RESULTS
“Based on performance across RMP network sites and recent clinical study execution.”

2-4 WEEKS

Achieved through centralized regulatory coordination and standardized start-up processes, significantly reducing timelines compared to the typical industry range of 6–12 weeks.

>90%

>90% Adoption Rate
Integrated CTMS and eSource platforms enable real-time data capture, communication, and oversight—far exceeding the industry average of less than 30%.

20-35%

20–35% Randomization Rate
EMR-driven pre-screening and targeted patient identification strategies increase randomization efficiency beyond standard industry benchmarks of 10–18%.

99%

<1% Major Protocol Deviations
Continuous quality control and centralized oversight ensure strict protocol adherence, outperforming typical industry rates of 3–7%.

85-92%

85–92% Retention Rate
Active patient engagement strategies and site-level support contribute to retention rates significantly above the industry average of 65–70%.

RMP integrates directly within active medical practices to standardize study execution, reduce variability, and deliver consistent performance across sites. Research Management Partners | Powered by Physician Management Partners SMO-MSO

KEY DIFFERENTIATORS “We offer the structure of a large network with the flexibility and patient access of independent practices.” RMP is designed to operate under real-world study pressure — including delayed enrollment, protocol complexity, and multi-site variability.